GL1X · GenesisL1 explorer

Ligand · END

END · 1,6:5,9:8,12:11,16-tetraanhydro-2,3,4,10,13,14-hexadeoxy-D-glycero-D-allo-D-gulo-heptadeca-2,13-dienitol

END, 1,6:5,9:8,12:11,16-tetraanhydro-2,3,4,10,13,14-hexadeoxy-D-glycero-D-allo-D-gulo-heptadeca-2,13-dienitol (C17 H24 O7, 340.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…

Component
END
Formula
C17 H24 O7
Class
ligand
Structures
2
PDB entries
1

Binding sites

END in 2 structures; the first of them:

  • 2Z93 · Crystal structure of Fab fragment of anti-ciguatoxin antibody 10C9 in complex with… · END C1 · binds HIS35A, ILE37, TRP47, TYR50, ASN58, ASP95, ASP101, TRP103 and 9 more
  • 2Z93 · Crystal structure of Fab fragment of anti-ciguatoxin antibody 10C9 in complex with… · END C1 · binds HIS35A, ILE37, TRP47, TYR50, ASN58, ASP95, ASP101, TRP103 and 9 more

Residues it binds most

TRP 2, ASN 2, ASP 2, HIS 2, TYR 2, ARG 2, GLN 2, ILE 2, PHE 2, PRO 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.